Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.09.2012 | Case report

Vincristine

Sensory neurotoxicity, treated with pregabalin: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Nakashima T, Kiba T, Ogawa Y, Kimura A, Kido M, Okikawa Y, Ito T, Saito A, Hosokawa A, Shintani H, Okada Y, Taniguchi T, Taniyama K, Kozawa K, Niimi H.A case of neurotoxicity reduced with pregabalin in R-CHOP chemotherapy for diffuse large B-cell lymphoma. Gan to Kagaku Ryoho 39: 809-812, No. 5, May 2012 - Japan Nakashima T, Kiba T, Ogawa Y, Kimura A, Kido M, Okikawa Y, Ito T, Saito A, Hosokawa A, Shintani H, Okada Y, Taniguchi T, Taniyama K, Kozawa K, Niimi H.A case of neurotoxicity reduced with pregabalin in R-CHOP chemotherapy for diffuse large B-cell lymphoma. Gan to Kagaku Ryoho 39: 809-812, No. 5, May 2012 - Japan
Metadaten
Titel
Vincristine
Sensory neurotoxicity, treated with pregabalin: case report
Publikationsdatum
01.09.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214200-00174

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Lenalidomide

Case report

Antineoplastics

Case report

Bevacizumab

Case report

Cytarabine

Case report

Fluorouracil